Kenneth B. Seamon

7.4k total citations · 3 hit papers
62 papers, 5.9k citations indexed

About

Kenneth B. Seamon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Kenneth B. Seamon has authored 62 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Pharmacology. Recurrent topics in Kenneth B. Seamon's work include Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Plant-based Medicinal Research (9 papers). Kenneth B. Seamon is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Plant-based Medicinal Research (9 papers). Kenneth B. Seamon collaborates with scholars based in United States, United Kingdom and Netherlands. Kenneth B. Seamon's co-authors include John W. Daly, William L. Padgett, Antonio Laurenza, Elizabeth McHugh Sutkowski, J D Robbins, N. J. DE SOUZA, H. Metzger, Carol A. Nelson, Sandra E. Pike and Lester T. May and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kenneth B. Seamon

62 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

1981 1.4k citations Kenneth B. Seamon, John W. Daly et al. profile →
Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

1981 674 citations Kenneth B. Seamon, John W. Daly profile →
Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

1981 646 citations Kenneth B. Seamon, John W. Daly PubMed profile →

Peers

Kenneth B. Seamon

CMN

PHYSI

IMMUN

ONCOL

Ronald Taussig United States

Alton L. Steiner United States

A. Donny Strosberg France

Yoram Salomon Israel

Pierre Morell United States

John W. Regan United States

Wai Yiu Cheung United States

Ole Thastrup Denmark

G. Schultz Germany

Dominic M. Desiderio United States

Ronald Taussig United States

Kenneth B. Seamon

4.6k ×1.3

1.7k ×1.0

CMN

761 ×0.8

PHYSI

291 ×0.6

IMMUN

410 ×0.8

ONCOL

Citations per year, relative to Kenneth B. Seamon Kenneth B. Seamon (= 1×) peers Ronald Taussig

Countries citing papers authored by Kenneth B. Seamon

Since Specialization

Citations

This map shows the geographic impact of Kenneth B. Seamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth B. Seamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth B. Seamon more than expected).

Fields of papers citing papers by Kenneth B. Seamon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth B. Seamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth B. Seamon. The network helps show where Kenneth B. Seamon may publish in the future.

Co-authorship network of co-authors of Kenneth B. Seamon

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth B. Seamon. A scholar is included among the top collaborators of Kenneth B. Seamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth B. Seamon. Kenneth B. Seamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seamon, Kenneth B., Sohini Chakraborty, Jim Cregg, et al.. (2024). 92 (PB080): Selective Inhibition of Active KRASG13C with RMC-8839 Reveals an Increased Dependence of Codon-13 KRAS-Mutant Cancers on Wild- Type RAS Isoforms. European Journal of Cancer. 211. 114618–114618. 1 indexed citations

Berns, Anton, Ulrik Ringborg, Julio E. Celis, et al.. (2015). Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies. Molecular Oncology. 10(5). 645–651. 9 indexed citations

Sievert, Michael K., et al.. (2002). Photoaffinity Labeling of Adenylyl Cyclase. Methods in enzymology on CD-ROM/Methods in enzymology. 345. 188–197. 2 indexed citations

Seamon, Kenneth B.. (1998). Specifications for biotechnology-derived protein drugs. Current Opinion in Biotechnology. 9(3). 319–325. 4 indexed citations

Moos, Malcolm, et al.. (1996). Purification of Bovine Brain Adenylyl Cyclase with a Novel Derivative of Forskolin: Evidence for a High Specific Activity form of the Enzyme. Preparative Biochemistry & Biotechnology. 26(2). 155–167. 1 indexed citations

Sutkowski, Elizabeth McHugh, J D Robbins, Wei‐Jen Tang, & Kenneth B. Seamon. (1996). Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin.. Molecular Pharmacology. 50(2). 299–305. 9 indexed citations

Speicher, L A, et al.. (1994). Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.. Molecular Pharmacology. 46(5). 866–872. 31 indexed citations

Sutkowski, Elizabeth McHugh, et al.. (1994). Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs.alpha.. Biochemistry. 33(43). 12852–12859. 105 indexed citations

Seamon, Kenneth B.. (1993). Evaluation of Genetic Stability. Biologicals. 21(2). 153–154. 1 indexed citations

10.

Sutkowski, Elizabeth McHugh, Frances A. Maher, Antonio Laurenza, Ian A. Simpson, & Kenneth B. Seamon. (1993). Interaction of 7-bromoacetyl-7-desacetylforskolin, an alkylating derivative of forskolin, with bovine brain adenylyl cyclase and human erythrocyte glucose transporter. Biochemistry. 32(9). 2415–2422. 3 indexed citations

11.

Finnegan, Alison, et al.. (1992). Identification of single amino acid substitutions in the staphylococcal nuclease protein that enhance and diminish. International Immunology. 4(12). 1399–1406. 6 indexed citations

12.

Vujcic, Luba K., Kenneth B. Seamon, S. C. Rastogi, et al.. (1991). High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1 _MN in Sera from Africa and the Americas. AIDS Research and Human Retroviruses. 7(10). 831–838. 50 indexed citations

13.

Speicher, L A, et al.. (1991). Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 30(34). 8371–8379. 60 indexed citations

14.

Lippincott‐Schwartz, Jennifer, Jonathan N. Glickman, Julie G. Donaldson, et al.. (1991). Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism.. The Journal of Cell Biology. 112(4). 567–577. 78 indexed citations

15.

Laurenza, Antonio, et al.. (1990). Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.. Molecular Pharmacology. 37(1). 69–74. 5 indexed citations

16.

Napolitano, Monica, Kenneth B. Seamon, & Warren J. Leonard. (1990). Identification of cell surface receptors for the Act-2 cytokine.. The Journal of Experimental Medicine. 172(1). 285–289. 18 indexed citations

17.

Moos, Malcolm, et al.. (1990). Immunoprecipitation of adenylate cyclase with an antibody to a carboxyl-terminal peptide from Gs.alpha.. Biochemistry. 29(38). 9079–9084. 19 indexed citations

18.

Nelson, Carol A. & Kenneth B. Seamon. (1988). Binding of [3H]forskolin to solubilized preparations of adenylate cyclase. Life Sciences. 42(14). 1375–1383. 13 indexed citations

19.

Cooper, Dermot M.F. & Kenneth B. Seamon. (1985). Dual regulation of adenylate cyclase.. PubMed. 19. 1–334. 10 indexed citations

20.

Seamon, Kenneth B. & John W. Daly. (1983). Forskolin, cyclic AMP and cellular physiology. Trends in Pharmacological Sciences. 4. 120–123. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact